Document:

Letter Agreement

 EXHIBIT 10.1 
  
 EXECUTION COPY 
  
 As of July 1, 2004 
  
 CDC Mortgage Capital Inc. 
 9 West 57th Street, 36th
Floor 
 New York, New York 10019 
  

					
	Attention:	  	Mr. Raymond Sullivan
			
	 	  	Re:	 	Second Amended and Restated Master Repurchase Agreement, dated as of June 23, 2003, as amended (the “Repurchase Agreement”), among CDC Mortgage Capital Inc.
(“Buyer”) and New Century Mortgage Corporation and NC Capital Corporation (each, a “Seller”)

  
 Ladies and Gentlemen: 
  
 In general, the Termination Date under the Repurchase Agreement is June 23,
2004 unless otherwise extended pursuant to Section 3(m) of the Repurchase Agreement and pursuant to Waiver and Amendment No. 5 to the Repurchase Agreement (“Amendment No. 5”), certain covenants under the Repurchase Agreement were
waived for the period ending on May 15, 2004. Seller and Buyer have entered into an extension letter, dated as of June 18, 2004, whereby the Termination Date has been extended until the close of business on July 7, 2004 and certain waivers of the
covenants until the close of business on July 7, 2004 . At the present time, the Seller has again requested that the Buyer extend the Termination Date and such waivers. 
  
 In consideration of the mutual agreements hereinafter set forth, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, Seller and Buyer hereby agree as follows: 
  

	1.	Pursuant to Section 3(m) of the Repurchase Agreement, Buyer hereby extends the Termination Date until the close of business on July 21, 2004. 

  

	2.	Each of the parties hereto agrees that the provisions of Amendment No. 5, as amended by the extensions of waiver, are hereby amended by deleting the date July 7, 2004 in each place
that it appears in Amendment No. 5 and substituting therefor the date July 21, 2004. 

  

	3.	Except as described herein, all of the terms of the Repurchase Agreement are hereby ratified and confirmed in all respects. 

  

	4.	All capitalized terms used herein and not defined herein shall have the respective meanings ascribed to them in the Repurchase Agreement. 

	5.	In the event that any provision of this agreement conflicts with any provision of the Repurchase Agreement or the Custodial and Disbursement Agreement, the terms of this agreement
shall control. 

  

	6.	This agreement shall not be assigned by the Seller without the prior written consent of the Buyer, which consent shall be in Buyer’s sole discretion. 

 

	7.	This agreement may be executed in any number of counterparts, each of which shall constitute an original agreement, and all of which together shall constitute one and the same
instrument, and either party hereto may execute this agreement by signing any such counterpart. 

  

	8.	This agreement shall be governed and construed in accordance with the laws of the State of New York without regard to conflicts of laws principles. 

 
 [SIGNATURE PAGE FOLLOWS] 
  

 -2- 

 Please indicate your acceptance and agreement by signing below where indicated and returning an
originally executed copy of this agreement to Seller. 
  

			
	Very truly yours,
	
	NEW CENTURY MORTGAGE CORPORATION
		
	By:	 	 /s/    KEVIN CLOYD

	Name:	 	Kevin Cloyd
	Title:	 	Executive Vice President
	
	NC CAPITAL CORPORATION
		
	By:	 	 /s/    KEVIN CLOYD

	Name:	 	Kevin Cloyd
	Title:	 	President

  
 Accepted and Agreed: 

 

			
	CDC MORTGAGE CAPITAL INC.
		
	By:	 	 /s/    WILLIAM BRANAGH

	Name:	 	William Branagh
	Title:	 	Managing Director
		
	By:	 	 /s/    ANTHONY MALANGA

	Name:	 	Anthony Malanga
	Title:	 	Managing DirectorAMENDMENT NO 1 TO RIGHTS AGREEMENT

 EXHIBIT 4.1 
  

AMENDMENT NO. 1 TO RIGHTS AGREEMENT 
  
 Amendment No. 1, dated as of July 7, 2004 (the “Amendment”) to the Shareholder Rights Agreement, dated as of May 17, 2001 (the “Rights
Agreement”), by and between Dynabazaar, Inc. (formerly known as FairMarket, Inc.), a Delaware corporation (the “Company”), and EquiServe Trust Company, N.A., a federally chartered trust company (the “Rights Agent”).

  
 W I T N E S S
E T H 
  
 WHEREAS, Section 27 of the Rights
Agreement provides that prior to the occurrence of a Section 11(a)(ii) Event (as defined therein), the Company and the Rights Agent shall, if the Board of Directors of the Company so directs, supplement or amend any provision of the Rights Agreement
as the Board of Directors of the Company may deem necessary or desirable without the approval of any holders of certificates representing shares of common stock of the Company; and 
  
 WHEREAS, a Section 11(a)(ii) Event has not yet occurred under the Rights Agreement; and 
  
 WHEREAS, the Board of Directors of the Company has determined that it is in
the best interests of the Company and its stockholders that the Rights Agreement be amended to provide for its final expiration effective July 31, 2004. 
  
 NOW, THEREFORE, in consideration of the premises and mutual agreements herein set forth, the parties hereby agree as follows: 
  
 1. Section 7(a) of the Rights Agreement is amended by deleting such Section
7(a) in its entirety and substituting therefore the following: 
  
 “(a) Subject to Section 7(e) hereof, the registered holder of any Right Certificate may exercise the Rights evidenced thereby (except as otherwise provided herein) in whole or in part at any time after the Distribution Date upon
surrender of the Right Certificate, with the form of election to purchase and the certificate on the reverse side thereof duly executed, to the Rights Agent at the office or offices of the Rights Agent designated for such purpose, together with
payment of the aggregate Exercise Price for the total number of one ten-thousandths of a share of Preferred Stock (or other securities, cash or other assets, as the case may be) as to which such surrendered Rights are then exercised, at or prior to
the earlier of (i) the Close of Business on July 31, 2004 (the “Final Expiration Date”), (ii) the time at which the Rights are redeemed as provided in Section 23 hereof or (iii) the time at which such Rights are exchanged as provided in
Section 24 hereof (the earlier of (i), (ii) or (iii) being herein referred to as the “Expiration Date”). Except as set forth in Section 7(e) hereof and notwithstanding any other provision of this Agreement, any Person who prior to the
Distribution Date becomes a record holder of shares of 

 Common Stock of the Company may exercise all of the rights of a registered holder of a Right Certificate with respect to
the Rights associated with such shares of Common Stock of the Company in accordance with the provisions of this Agreement, as of the date such Person becomes a record holder of shares of Common Stock of the Company.” 
  
 2. Any term used herein and not defined shall have the meaning ascribed to
such term in the Rights Agreement. 
  
 IN WITNESS WHEREOF, the
parties hereto have caused this Amendment to be duly executed as of the day and year first above written. This Amendment may be executed in one or more counterparts all of which shall be considered one and the same amendment and each of which shall
be deemed to be an original. 
  

							
	 ATTEST:
	 	 DYNABAZAAR, INC.

				
	 By:
	 	 /s/ Jared Landaw

	 	 By:
	 	 /s/ Melvyn Brunt

	 Name:
	 	 Jared Landaw
	 	 	 	 Melvyn Brunt

	 	 	 	 	 	 	 Chief Financial Officer

		
	 ATTEST:
	 	 EQUISERVE TRUST COMPANY, N.A.,

	 	 	 	 	 as Rights Agent

				
	 By:
	 	 /s/ Monique Hughes

	 	 By:
	 	 /s/ Carol Molvey-Eori

	 Name:
	 	 Monique Hughes
	 	 	 	 Carol Molvey-Eori

	 	 	 	 	 	 	 Managing Director

 DYNABAZAAR, INC. 
  
 OFFICER’S CERTIFICATE 
  

The undersigned, pursuant to Section 27 of the Rights Agreement, dated as of May 17, 2001 (the “Rights Agreement”), by and between
Dynabazaar, Inc. (formerly known as FairMarket, Inc.), a Delaware corporation, and EquiServe Trust Company, N.A., a federally chartered trust company, hereby certifies that Amendment No. 1 to the Rights Agreement is in compliance with the terms of
Section 27 of the Rights Agreement. 
  
 IN WITNESS WHEREOF, I have
executed this Certificate as of July 7, 2004. 
  

	
	 /s/ Melvyn Brunt

	 Melvyn Brunt

	 Chief Financial OfficerWarrant to Purchase Stock  - Series E Preferred

 EXHIBIT 4.3 
  

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAW, AND MAY
NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 AND AN EXEMPTION UNDER APPLICABLE STATE LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS
COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED. 
  
 WARRANT TO
PURCHASE STOCK 
  

			
	 Corporation:
	  	IntraLase Corp.
	 Number of Shares:
	  	31,300
	 Class of Stock:
	  	Series E Preferred Stock
	 Initial Exercise Price:
	  	$5.11
	 Issue Date:
	  	July 12, 2001
	 Expiration Date:
	  	July 12, 2008

  
 THIS WARRANT CERTIFIES
THAT, for the agreed upon value of $1.00 and for other good and valuable consideration, SILICON VALLEY BANK (“Holder”) is entitled to purchase the number of fully paid and nonassessable shares of the class of securities (the
“Shares”) of the corporation (the “Company”) at the initial exercise price per Share (the “Warrant Price”), all as set forth above and as adjusted pursuant to Article 2 of this Warrant, subject to the provisions and
upon the terms and conditions set forth in this Warrant. 
  
 ARTICLE 1.
EXERCISE. 
  
 1.1 Method of Exercise. Holder may
exercise this Warrant by delivering a duly executed Notice of Exercise in substantially the form attached as Appendix 1 to the principal office of the Company. Unless Holder is exercising the conversion right set forth in Section 1.2, Holder shall
also deliver to the Company a check for the aggregate Warrant Price for the Shares being purchased. 
  
 1.2 Conversion Right. In lieu of exercising this Warrant as specified in Section 1.1, Holder may from time to time convert this Warrant, in whole
or in part, into a number of Shares determined by dividing (a) the aggregate fair market value of the Shares or other securities otherwise issuable upon exercise of this Warrant minus the aggregate Warrant Price of such Shares by (b) the fair market
value of one Share. The fair market value of the Shares shall be determined pursuant to Section 1.3. 
  
 1.3 Fair Market Value. If the Shares are traded in a public market, the fair market value of the Shares shall be the closing price of the Shares
(or the closing price of the Company’s stock into which the Shares are convertible) reported for the business day immediately before Holder delivers its Notice of Exercise to the Company. If the Shares are not traded in a public market, the
Board of Directors of the Company shall determine fair market value in its reasonable good faith judgment. 
  
 1.4 Delivery of Certificate and New Warrant. Promptly after Holder exercises or converts this Warrant, the Company shall deliver to Holder
certificates for the Shares acquired and, if this Warrant has not been fully exercised or converted and has not expired, a new Warrant representing the Shares not so acquired. 
  

 1 

 1.5 Replacement of Warrants. On receipt of evidence reasonably satisfactory to the Company of the
loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company or, in the case of mutilation, or surrender and
cancellation of this Warrant, the Company shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor. 
  
 1.6 Assumption on Sale, Merger, or Consolidation of the Company. 
  
 1.6.1 “Acquisition”. For the purpose of this Warrant, “Acquisition” means any sale, license, or
other disposition of all or substantially all of the assets of the Company, or any reorganization, consolidation or merger of the Company where the holders of the Company’s securities before the transaction beneficially own less than 50% of the
outstanding voting securities of the surviving entity after the transaction. 
  
 1.6.2 Assumption of Warrant. Upon the closing of any Acquisition, the successor entity shall assume the obligations of this Warrant, and this Warrant shall be exercisable for the same securities, cash, and
property as would be payable for the Shares issuable upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on the record date for the Acquisition and subsequent closing. The Initial Exercise Price and/or number
of Shares shall be adjusted accordingly. 
  
 ARTICLE 2. ADJUSTMENTS TO THE
SHARES. 
  
 Reference is made to the Fourth Amended and
Restated Certificate of Incorporation of IntraLase Corp. filed with the Secretary of State of the State of Delaware on October 13, 2000 (the “Certificate”). The Holder hereby agrees that to the extent that an event or occurrence arises
that is encompassed within the provisions of Sections 2.1, 2.2 and 2.3 below (the “Dilution Provisions”) and that also triggers a change in the “Series B Conversion Price” (as defined and referred to in the Certificate) pursuant
to Section C4 thereof (and while such conversion price mechanism of the Certificate remains in effect and otherwise prior to any mandatory conversion of the Series B Preferred Stock of the Company), then the Dilution Provisions shall not be
effective or applicable to any such specific event or occurrence relating to any such change in such Series E Conversion Price, provided, however the Dilution Provisions shall be fully effective and applicable (A) under all other events and
occurrences and (B) to all other effects and impacts of any such event or occurrence that do not relate to or result in changes in the Series B Conversion Price while such conversion price mechanism of the Certificate remains in effect and otherwise
prior to any mandatory conversion of the Series E Preferred Stock of the Company. 
  
 2.1 Stock Dividends, Splits, Etc. If the Company declares or pays a dividend on its common stock (or the Shares, if the Shares are securities other than common stock) payable in common stock, or other
securities, subdivides the outstanding common stock into a greater amount of common stock, or, if the Shares are securities other than common stock, subdivides the Shares in a transaction that increases the amount of common stock into which the
Shares are convertible, then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without cost to Holder, the total number and kind of securities to which Holder would have been entitled had Holder owned the Shares of record
as of the date the dividend or subdivision occurred. If the outstanding shares are combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Initial Exercise Price shall be proportionately increased. 

 

 2 

 2.2 Reclassification, Exchange, Combinations or Substitution. Upon any reclassification, exchange,
substitution, or other event that results in a change of the number and/or class of the securities issuable upon exercise or conversion of this Warrant, Holder shall be entitled to receive, upon exercise or conversion of this Warrant, the number and
kind of securities and property that Holder would have received for the Shares if this Warrant had been exercised immediately before such reclassification, exchange, substitution or other event. Such an event shall include any automatic conversion
of the outstanding or issuable securities of the Company of the same class or series as the Shares to common stock pursuant to the terms of the Company’s Certificate of Incorporation upon the closing of a registered public offering of the
Company’s common stock. The Company or its successor shall promptly issue to Holder a new Warrant for such new securities or other property. The new Warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable
to the adjustments provided for in this Article 2 including, without limitation, adjustments to the Initial Exercise Price and to the number of securities or property issuable upon exercise of the new Warrant. The provisions of this Section 2.2
shall similarly apply to successive reclassifications, exchanges, substitutions, or other events. 
  
 2.3 Adjustments for Diluting Issuances. The Warrant Price and the number of Shares issuable upon exercise of this Warrant or, if the Shares are
Preferred Stock, the number of shares of common stock issuable upon conversion of the Shares, shall be subject to adjustment, from time to time in the manner set forth in the Company’s Certificate of Incorporation. The provisions set forth for
the Shares in the Company’s Certificate of Incorporation relating to the above in effect as of the Issue Date may not be amended, modified or waived, without the prior written consent of Holder unless such amendment, modification or waiver
affects Holder in the same manner as they affect all other shareholders of the same series of shares granted to the Holder. 
  
 2.4 No Impairment. The Company shall not, by amendment of its Certificate of Incorporation or through a reorganization, transfer of assets,
consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by the Company, but shall at all
times in good faith assist in carrying out of all the provisions of this Article 2 and in taking all such action as may be necessary or appropriate to protect Holder’s rights under this Article against impairment. 
  
 2.5 Fractional Shares. No fractional Shares shall be issuable upon
exercise or conversion of the Warrant and the number of Shares to be issued shall be rounded down to the nearest whole Share. If a fractional share interest arises upon any exercise or conversion of the Warrant, the Company shall eliminate such
fractional share interest by paying Holder the amount computed by multiplying the fractional interest by the fair market value of a full Share. 
  
 2.6 Certificate as to Adjustments. Upon each adjustment of the Warrant Price, the Company shall promptly notify Holder in writing, and, at the
Company’s expense, promptly compute such adjustment, and furnish Holder with a certificate of its Chief Financial Officer setting forth such adjustment and the facts upon which such adjustment is based. The Company shall, upon written request,
furnish Holder a certificate setting forth the Warrant Price in effect upon the date thereof and the series of adjustments leading to such Warrant Price. 
  

 3 

 ARTICLE 3. REPRESENTATIONS AND COVENANTS OF THE COMPANY. 
  
 3.1 Representations and Warranties. The Company represents and
warrants to the Holder as follows: 
  
 (a) The initial Warrant
Price referenced on the first page of this Warrant is not greater than (i) the price per share at which the Shares were last issued in an arms-length transaction in which at least $500,000 of the Shares were sold and (ii) the fair market value of
the Shares as of the date of this Warrant. 
  
 (b) All Shares
which may be issued upon the exercise of the purchase right represented by this Warrant, and all securities, if any, issuable upon conversion of the Shares, shall, upon issuance, be duly authorized, validly issued, fully paid and nonassessable, and
free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal and state securities laws. 
  
 (c) The capitalization table previously provided to Holder remains true and complete as of the Issue Date. 
  
 3.2 Notice of Certain Events. If the Company proposes at any time (a)
to declare any dividend or distribution upon its common stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to offer for subscription pro rata to the holders of any class or series of its
stock any additional shares of stock of any class or series or other rights; (c) to effect any reclassification or recapitalization of common stock; (d) to merge or consolidate with or into any other corporation, or sell, lease, license, or convey
all or substantially all of its assets, or to liquidate, dissolve or wind up; or (e) offer holders of registration rights the opportunity to participate in an underwritten public offering of the company’s securities for cash, then, in
connection with each such event, the Company shall give Holder (1) at least 10 days prior written notice of the date on which a record will be taken for such dividend, distribution, or subscription rights (and specifying the date on which the
holders of common stock will be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in (c) and (d) above; (2) in the case of the matters referred to in (c) and (d) above at least 10 days prior written
notice of the date when the same will take place (and specifying the date on which the holders of common stock will be entitled to exchange their common stock for securities or other property deliverable upon the occurrence of such event); and (3)
in the case of the matter referred to in (e) above, the same notice as is given to the holders of such registration rights. 
  
 3.3 Registration Under Securities Act of 1933, As Amended. The Company agrees that the Shares or, if the Shares are convertible into common stock
of the Company, such common stock, shall be subject to the registration rights set forth in the Company’s Third Amended and Restated Registration Rights Agreement dated October 18, 2000 or similar agreement. The provisions set forth in the
Company’s Investors’ Right Agreement or similar agreement relating to the above in effect as of the Issue Date may not be amended, modified or waived in a manner uniquely affecting the Holder without the prior written consent of Holder.
Further, it is agreed that the lockup provision, as now in effect, as set forth in Section 16(h) of the foregoing Third Amended and Restated Registration Rights Agreement shall apply to this Warrant and to the Shares hereunder. 
  

 4 

 ARTICLE 4. REPRESENTATIONS, WARRANTIES OF THE HOLDER. The Holder represents and warrants to the Company as
follows: 
  
 4.1 Purchase for Own Account. Except for
transfers to Holder’s affiliates, this Warrant and the securities to be acquired upon exercise of this Warrant by the Holder will be acquired for investment for the Holder’s account, not as a nominee or agent, and not with a view to the
public resale or distribution within the meaning of the 1933 Act, and the Holder has no present intention of selling, granting any participation in, or otherwise distributing the same. If not an individual, the Holder also represents that the Holder
has not been formed for the specific purpose of acquiring this Warrant or the Shares. 
  
 4.2 Disclosure of Information. The Holder has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition
of this Warrant and its underlying securities. The Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to
obtain additional information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to the Holder or to which the Holder has access.

  
 4.3 Investment Experience. The Holder understands that
the purchase of this Warrant and its underlying securities involves substantial risk. The Holder: (i) has experience as an investor in securities of companies in the development stage and acknowledges that the Holder is able to fend for itself, can
bear the economic risk of such Holders s investment in this Warrant and its underlying securities and has such knowledge and experience in financial or business matters that the Holder is capable of evaluating the merits and risks of its investment
in this Warrant and its underlying securities and/or (ii) has a preexisting personal or business relationship with the Company and certain of its officers, directors or controlling persons of a nature and duration that enables the Holder to be aware
of the character, business acumen and financial circumstances of such persons. 
  
 4.4 Accredited Investor Status. The Holder is an “accredited investor” within the meaning of Regulation D promulgated under the 1933 Act. 
  
 ARTICLE 5. MISCELLANEOUS. 
  
 5.1 Term. This Warrant is exercisable in whole or in part at any time and from time to time on or before the Expiration Date. 
  
 5.2 Legends. This Warrant and the Shares (and the securities issuable,
directly or indirectly, upon conversion of the Shares, if any) shall be imprinted with a legend in substantially the following form: 
  
 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR UNDER ANY APPLICABLE STATE LAWS, AND MAY NOT BE SOLD, PLEDGED OR
OTHER WISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THERE OF UNDER SUCH ACT AND AN EXEMPTION UNDER APPLICABLE STATE LAW OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL THAT SUCH
REGISTRATION IS NOT REQUIRED. 
  

 5 

 5.3 Compliance with Securities Laws on Transfer. This Warrant and the Shares issuable upon
exercise of this Warrant (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole or in part without compliance with applicable federal and state securities laws by the
transferor and the transferee (including, without limitation, the delivery of investment representation letters and legal opinions reasonably satisfactory to the Company, as reasonably requested by the Company). The Company shall not require Holder
to provide an opinion of counsel if the transfer is to an affiliate of Holder or if there is no material question as to the availability of current information as referenced in Rule 144(c), Holder represents that it has complied with Rule 144(d) and
(e) in reasonable detail, the selling broker represents that it has complied with Rule 144(f), and the Company is provided with a copy of Holder’s notice of proposed sale. 
  
 5.4 Transfer Procedure. Subject to the provisions of Section 5.3, Holder may transfer all or part of this Warrant or
the Shares issuable upon exercise of this Warrant (or the securities issuable, directly or indirectly, upon conversion of the Shares, if any) to Silicon Valley Bancshares, or The Silicon Valley Bank Foundation, or to any affiliate of Holder at any
time without prior notice to Company; provided, however, if Holder transfers this warrant to any other transferee, Holder will give the Company notice of the portion of the Warrant being transferred with the name, address and taxpayer identification
number of the transferee and surrendering this Warrant to the Company for reissuance to the transferee(s) (and Holder if applicable). The Company may refuse to transfer this Warrant to any person who directly competes with the Company unless the
Company’s stock is publicly traded. 
  
 5.5 Notices.
All notices and other communications from the Company to the Holder, or vice versa, shall be deemed delivered and effective when given personally or mailed by first-class registered or certified mail, postage prepaid, at such address as may have
been furnished to the Company or the Holder, as the case may be, in writing by the Company or such holder from time to time. All notices to the Holder shall be addressed as follows: 
  
 Silicon Valley Bank 
 Attn: Treasury Department 
 3003 Tasman Drive, HG 110 
 Santa Clara, CA 95054 
  
 5.6
Waiver. This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought. 

 
 5.7 Attorney’s Fees. In the event of any dispute between the
parties concerning the terms and provisions of this Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable 
  
 5.8 Automatic Conversion upon Expiration. In the event that, upon the
Expiration Date, the fair market value of one Share (or other security issuable upon the exercise hereof) as determined in accordance with Section 1.3 above is greater than the Exercise Price in effect on such date, then 

  

 6 

 
this Warrant shall automatically be deemed on and as of such date to be converted pursuant to Section 1.2 above as to all Shares (or such other securities)
for which it shall not previously have been exercised or converted, and the Company shall promptly deliver a certificate representing the Shares (or such other securities) issued upon such conversion to the Holder. 
  
 5.9 Rights as Stockholder. Except as expressly provided in Section 2.3
hereof, no Holder of this Warrant, as such, shall be entitled to vote or receive dividends or be deemed the holder of the Shares or any other securities of the Company which may at any time be issuable on the exercise hereof for any purpose, nor
shall anything contained herein be construed to confer upon the holder of this Warrant, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any
meeting thereof, or to receive notice of meetings, or to receive dividends or subscription rights or otherwise until this Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have become deliverable, as
provided herein. 
  
 5.10 Governing Law. This Warrant shall
be governed by and construed in accordance with the laws of the State of California, without giving effect to its principles regarding conflicts of law. 
  

			
	 “COMPANY”
  
 INTRALASE CORP.

		
	 By:
	 	     /S/    RANDY
ALEXANDER

			
	Name:	 	 Randy Alexander

	 	 	(Print)
	 Title:
	 	Chairman of the Board, President or Vice President
		
	 By:
	 	 /S/    SHELLEY THUREN

	Name:	 	 Shelley Thuren

	 	 	(Print)
	 Title:
	 	Chief Financial Officer, Secretary, Assistant Treasurer or Assistant Secretary

  

			
	 “HOLDER”
  
 SILICON VALLEY BANK

		
	 By:
	 	     /S/    GARY
REAGAN

			
	Name:	 	 Gary Reagan

	 	 	(Print)
	 Title:
	 	 V.P.

  

 7 

 APPENDIX 1 
  
 NOTICE OF EXERCISE 
  
 1. Holder elects to purchase              shares of the Common/Series
             Preferred [strike one] Stock of IntraLase Corp. pursuant to the terms of the attached Warrant, and tenders payment of the purchase price of the shares in full.

  
 1. Holder elects to convert the attached Warrant into
Shares/cash [strike one] in the manner specified in the Warrant. This conversion is exercised for              of the Shares covered by the Warrant. 
  
 [Strike paragraph that does not apply] 
  
 2. Please issue a certificate or certificates representing the shares in the
name specified below: 
  
  

					
	 	  	  

 (Holder’s Name)
	  	 
			
	 	  	
  

 (Address)
	  	 

  
 3. The undersigned
represents it is acquiring the shares solely for its own account and not as a nominee for any other party and not with a view toward the resale or distribution except in compliance with applicable securities laws. 
  

			
	 HOLDER:
  

		
	 By:
	 	  

			
	Name:	 	  

	 Title:
	 	  

  
  
 ___________________ 
 (Date) 
  

 A-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}]]